Journal Article

Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis

Kinoshita, Naohiko, Kakimoto, Kazuki, Numa, Keijiro, Miyazaki, Takako, Nishikawa, Hiroki, Hirata, Yuki, Kawasaki, Yuka, Koshiba, Ryoji, Inoue, Takuya, Higuchi, Kazuhide, Tatsumi, Yoshihiro, Takeuchi, Toshihisa, Fukunishi, Shinya, Nakata, Satoshi, Ota, Kazuhiro, Kojima, Yuichi, Tawa, Hideki, Nakamura, Shiro, Sakiyama, Naokuni

2022

Overview

Background and Aims: The calcineurin inhibitor tacrolimus is reportedly effective for moderate/severe ulcerative colitis (UC); however, it is also reportedly associated with nephrotoxicity. We investigated the risk factors for tacrolimus-induced nephrotoxicity and whether renal impairment adversely affected the outcomes of tacrolimus treatment in patients with UC. Methods: We conducted a retrospective study of 93 patients with UC who were administered tacrolimus leading to high trough levels (10–15 ng/mL) for 2 weeks and low trough levels (5–10 ng/mL) for 3 months. Results: Acute kidney injury (AKI) occurred in 44 patients (47.3%) during tacrolimus treatment. Of these patients, 34 (36.6%) developed AKI during the high trough phase and 17 (18.3%) developed AKI when the trough value exceeded the original target value of 15 ng/mL. Multivariate logistic regression analysis revealed that the male sex was significantly associated with AKI (p = 0.002, AOR = 4.38, 95% CI [1.69–11.3]). Clinical remission rate after 4, 8, 12, and 24 weeks of tacrolimus treatment in patients with AKI was lower than that in patients without AKI. Six patients (6.5%) had chronic kidney disease (CKD) after tacrolimus treatment completion, and all patients with CKD developed AKI during treatment. The median duration of treatment with no improvement in AKI was significantly longer in patients with CKD than in those without CKD (p = 0.016). Conclusion: We revealed the risk factors for tacrolimus-induced nephrotoxicity. Renal impairment occurrence adversely affected the tacrolimus treatment outcome; therefore, it is important to carefully administer tacrolimus to prevent renal impairment.

• Publisher: S. Karger AG
• Subject: Acute Kidney Injury / Acute Kidney Injury - chemically induced / Acute Kidney Injury - drug therapy / Acute Kidney Injury - epidemiology / Colitis, Ulcerative / Colitis, Ulcerative - drug therapy / Humans / Immunosuppressive Agents / Immunosuppressive Agents - adverse effects / Male / Renal Insufficiency, Chronic / Research Article / Retrospective Studies / Risk Factors / Tacrolimus / Tacrolimus - adverse effects / Treatment Outcome